Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

A Review of Wood Dust Longitudinal Health Studies: Implications for an Occupational Limit Value.

Holm SE, Festa JL.

Dose Response. 2019 Feb 28;17(1):1559325819827464. doi: 10.1177/1559325819827464. eCollection 2019 Jan-Mar. Review.

2.

Dispositional resilience in treatment-seeking patients with obsessive-compulsive disorder and its association with treatment outcome.

Holm SEH, Hansen B, Kvale G, Eilertsen T, Johnsen BH, Hystad SW, Solem S.

Scand J Psychol. 2019 Jun;60(3):243-251. doi: 10.1111/sjop.12531. Epub 2019 Mar 6.

PMID:
30841013
3.

Prevalence of drug use among adults with intellectual disabilities compared with drug use in the general population.

Hove O, Biringer E, Havik OE, Assmus J, Braatveit KJ, Holm SEH, Hermann M.

Pharmacoepidemiol Drug Saf. 2019 Mar;28(3):337-344. doi: 10.1002/pds.4741. Epub 2019 Feb 12. Erratum in: Pharmacoepidemiol Drug Saf. 2019 Aug;28(8):1152-1153.

PMID:
30747466
4.

The Dimensional Obsessive-Compulsive Scale: Development and Validation of a Short Form (DOCS-SF).

Eilertsen T, Hansen B, Kvale G, Abramowitz JS, Holm SEH, Solem S.

Front Psychol. 2017 Sep 5;8:1503. doi: 10.3389/fpsyg.2017.01503. eCollection 2017.

5.

Parental socioeconomic status and child intellectual functioning in a Norwegian sample.

Eilertsen T, Thorsen AL, Holm SE, Bøe T, Sørensen L, Lundervold AJ.

Scand J Psychol. 2016 Oct;57(5):399-405. doi: 10.1111/sjop.12324.

PMID:
27589048
6.

High Cytokine Levels in Tonsillitis Secretions Regardless of Presence of Beta-Hemolytic Streptococci.

Skovbjerg S, Roos K, Olofsson S, Lindh M, Ljung A, Hynsjö L, Holm SE, Adlerberth I, Wold AE.

J Interferon Cytokine Res. 2015 Sep;35(9):682-9. doi: 10.1089/jir.2014.0123. Epub 2015 May 18.

PMID:
26060912
7.

Mecillinam resistance and outcome of pivmecillinam treatment in uncomplicated lower urinary tract infection in women.

Monsen TJ, Holm SE, Ferry BM, Ferry SA.

APMIS. 2014 Apr;122(4):317-23. doi: 10.1111/apm.12147.

PMID:
24738161
8.

Responsiveness of the one-leg hop test and the square hop test to fatiguing intermittent aerobic work and subsequent recovery.

Ros AG, Holm SE, Fridén C, Heijne AI.

J Strength Cond Res. 2013 Apr;27(4):988-94. doi: 10.1519/JSC.0b013e31825feb5b.

PMID:
22706574
9.

Exposures from chrysotile-containing joint compound: evaluation of new model relating respirable dust to fiber concentrations.

Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE.

Risk Anal. 2013 Jan;33(1):161-76. doi: 10.1111/j.1539-6924.2012.01847.x. Epub 2012 May 29.

PMID:
22642316
10.

More on the dynamics of dust generation: the effects of mixing and sanding chrysotile, calcium carbonate, and other components on the characteristics of joint-compound dusts.

Berman DW, Brorby GP, Sheehan PJ, Bogen KT, Holm SE.

Ann Occup Hyg. 2012 Aug;56(7):852-67. doi: 10.1093/annhyg/mes008. Epub 2012 Mar 16.

PMID:
22425655
11.

Characteristics of Escherichia coli causing persistence or relapse of urinary tract infections: phylogenetic groups, virulence factors and biofilm formation.

Ejrnæs K, Stegger M, Reisner A, Ferry S, Monsen T, Holm SE, Lundgren B, Frimodt-Møller N.

Virulence. 2011 Nov-Dec;2(6):528-37. doi: 10.4161/viru.2.6.18189. Epub 2011 Nov 1.

PMID:
22030858
12.

Chamber for testing asbestos-containing products: validation and testing of a re-created chrysotile-containing joint compound.

Sheehan PJ, Brorby GP, Berman DW, Bogen KT, Holm SE.

Ann Occup Hyg. 2011 Aug;55(7):797-809. doi: 10.1093/annhyg/mer048. Epub 2011 Jul 26.

PMID:
21795244
13.

Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure.

Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE.

Inhal Toxicol. 2011 Jun;23(7):372-91. doi: 10.3109/08958378.2011.575413. Erratum in: Inhal Toxicol. 2012 Jan;24(1):80.

PMID:
21639707
14.

Potential artifacts associated with historical preparation of joint compound samples and reported airborne asbestos concentrations.

Brorby GP, Sheehan PJ, Berman DW, Bogen KT, Holm SE.

J Occup Environ Hyg. 2011 May;8(5):271-8. doi: 10.1080/15459624.2011.566805.

PMID:
21462068
15.

The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results.

Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE.

Inhal Toxicol. 2010 Sep;22(11):937-62. doi: 10.3109/08958378.2010.497818. Erratum in: Inhal Toxicol. 2012 Jan;24(1):80.

PMID:
20695727
16.

High cytokine levels in perforated acute otitis media exudates containing live bacteria.

Skovbjerg S, Roos K, Nowrouzian F, Lindh M, Holm SE, Adlerberth I, Olofsson S, Wold AE.

Clin Microbiol Infect. 2010 Sep;16(9):1382-8. doi: 10.1111/j.1469-0691.2009.03083.x.

17.

Re-creation of historical chrysotile-containing joint compounds.

Brorby GP, Sheehan PJ, Berman DW, Greene JF, Holm SE.

Inhal Toxicol. 2008 Sep;20(11):1043-53. doi: 10.1080/08958370802290595 . Erratum in: Inhal Toxicol. 2012 Jan;24(1):80.

18.

A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles.

Bernstein DM, Donaldson K, Decker U, Gaering S, Kunzendorf P, Chevalier J, Holm SE.

Inhal Toxicol. 2008 Sep;20(11):1009-28. doi: 10.1080/08958370802259053 . Erratum in: Inhal Toxicol. 2012 Jan;24(1):80.

19.

Spray bacteriotherapy decreases middle ear fluid in children with secretory otitis media.

Skovbjerg S, Roos K, Holm SE, Grahn Håkansson E, Nowrouzian F, Ivarsson M, Adlerberth I, Wold AE.

Arch Dis Child. 2009 Feb;94(2):92-8. doi: 10.1136/adc.2008.137414. Epub 2008 Aug 19.

PMID:
18713796
20.

Specialized knowledge and skills in feeding, eating, and swallowing for occupational therapy practice.

Clark GF, Avery-Smith W, Wold LS, Anthony P, Holm SE; Eating and Feeding Task Force; Commission on Practice.

Am J Occup Ther. 2007 Nov-Dec;61(6):686-700. No abstract available.

PMID:
18217635
22.

Chemical speciation and bioaccessibility of arsenic and chromium in chromated copper arsenate-treated wood and soils.

Nico PS, Ruby MV, Lowney YW, Holm SE.

Environ Sci Technol. 2006 Jan 1;40(1):402-8.

PMID:
16433378
23.

Percutaneous absorption of arsenic from environmental media.

Lowney YW, Ruby MV, Wester RC, Schoof RA, Holm SE, Hui XY, Barbadillo S, Maibach HI.

Toxicol Ind Health. 2005 Mar;21(1-2):1-14.

PMID:
15986571
24.

Chemical structure of arsenic and chromium in CCA-treated wood: implications of environmental weathering.

Nico PS, Fendorf SE, Lowney YW, Holm SE, Ruby MV.

Environ Sci Technol. 2004 Oct 1;38(19):5253-60.

PMID:
15506225
25.

Gene expression fingerprints of largemouth bass (Micropterus salmoides) exposed to pulp and paper mill effluents.

Denslow ND, Kocerha J, Sepúlveda MS, Gross T, Holm SE.

Mutat Res. 2004 Aug 18;552(1-2):19-34.

PMID:
15288539
26.

The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study.

Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ.

Scand J Infect Dis. 2004;36(4):296-301.

PMID:
15198188
27.

In vivo percutaneous absorption of arsenic from water and CCA-treated wood residue.

Wester RC, Hui X, Barbadillo S, Maibach HI, Lowney YW, Schoof RA, Holm SE, Ruby MV.

Toxicol Sci. 2004 Jun;79(2):287-95. Epub 2004 Mar 31.

PMID:
15056813
28.

Specialized knowledge and skills in eating and feeding for occupational therapy practice.

Clark GF, Avery-Smith W, Wolf LS, Anthony P, Holm SE, Hertfelder SD, Youngstrom MJ; Eating and Feeding Task Force; Commission on Practice.

Am J Occup Ther. 2003 Nov-Dec;57(6):660-78. No abstract available.

PMID:
14661785
29.

Is hydrogen peroxide responsible for the inhibitory activity of alpha-haemolytic streptococci sampled from the nasopharynx?

Tano K, Grahn Håkansson E, Wallbrandt P, Rönnqvist D, Holm SE, Hellström S.

Acta Otolaryngol. 2003 Aug;123(6):724-9.

PMID:
12953772
30.

Selected resin acids in effluent and receiving waters derived from a bleached and unbleached kraft pulp and paper mill.

Quinn BP, Booth MM, Delfino JJ, Holm SE, Gross TS.

Environ Toxicol Chem. 2003 Jan;22(1):214-8. Erratum in: Environ Toxicol Chem. 2003 Apr;22(4):943.

PMID:
12503767
31.

Effects of pulp and paper mill effluents on reproductive success of largemouth bass.

Sepúlveda MS, Quinn BP, Denslow ND, Holm SE, Gross TS.

Environ Toxicol Chem. 2003 Jan;22(1):205-13.

PMID:
12503766
32.

Bacterial interference between pathogens in otitis media and alpha-haemolytic Streptococci analysed in an in vitro model.

Tano K, Håkansson EG, Holm SE, Hellström S.

Acta Otolaryngol. 2002 Jan;122(1):78-85.

PMID:
11876603
33.

A nasal spray with alpha-haemolytic streptococci as long term prophylaxis against recurrent otitis media.

Tano K, Grahn Håkansson E, Holm SE, Hellström S.

Int J Pediatr Otorhinolaryngol. 2002 Jan 11;62(1):17-23.

PMID:
11738689
34.

Assessment of reproductive effects in largemouth bass (Micropterus salmoides) exposed to bleached/unbleached kraft mill effluents.

Sepúlveda MS, Ruessler DS, Denslow ND, Holm SE, Schoeb TR, Gross TS.

Arch Environ Contam Toxicol. 2001 Nov;41(4):475-82.

PMID:
11598785
36.

Inhibition of OM pathogens by alpha-hemolytic streptococci from healthy children, children with SOM and children with rAOM.

Tano K, Grahn-Håkansson E, Holm SE, Hellström S.

Int J Pediatr Otorhinolaryngol. 2000 Dec 22;56(3):185-90.

PMID:
11137592
37.

Treatment of recurrent tonsillopharyngitis.

Holm SE.

J Antimicrob Chemother. 2000 Feb;45 Suppl:31-5. No abstract available.

PMID:
10759360
39.

Tolerance and efficacy of interfering alpha-streptococci in recurrence of streptococcal pharyngotonsillitis: a placebo-controlled study.

Falck G, Grahn-Håkansson E, Holm SE, Roos K, Lagergren L.

Acta Otolaryngol. 1999;119(8):944-8.

PMID:
10728939
40.

Allele substitution of the streptokinase gene reduces the nephritogenic capacity of group A streptococcal strain NZ131.

Nordstrand A, McShan WM, Ferretti JJ, Holm SE, Norgren M.

Infect Immun. 2000 Mar;68(3):1019-25.

41.
42.

Pathogenic mechanism of acute post-streptococcal glomerulonephritis.

Nordstrand A, Norgren M, Holm SE.

Scand J Infect Dis. 1999;31(6):523-37. Review.

PMID:
10680980
43.

The role of fiberoptic endoscopy in dysphagia rehabilitation.

Hoppers P, Holm SE.

J Head Trauma Rehabil. 1999 Oct;14(5):475-85. Review.

PMID:
10653943
46.
47.

In vitro inhibition of S. pneumoniae, nontypable H. influenzae and M. catharralis by alpha-hemolytic streptococci from healthy children.

Tano K, Olofsson C, Grahn-Håkansson E, Holm SE.

Int J Pediatr Otorhinolaryngol. 1999 Jan 25;47(1):49-56.

PMID:
10206394
48.

Identification of domains involved in superantigenicity of streptococcal pyrogenic exotoxin F (SpeF).

Eriksson A, Holm SE, Norgren M.

Microb Pathog. 1998 Nov;25(5):279-90.

PMID:
9878456
49.

Streptococcal DNase B is immunologically identical to superantigen SpeF but involves separate domains.

Eriksson A, Eriksson B, Holm SE, Norgren M.

Clin Diagn Lab Immunol. 1999 Jan;6(1):133-6.

50.

Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome.

Eriksson BK, Andersson J, Holm SE, Norgren M.

Clin Infect Dis. 1998 Dec;27(6):1428-36.

PMID:
9868656

Supplemental Content

Support Center